Nazione: Armenia
Lingua: inglese
Fonte: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
camphor, salicylic acid
Vetprom AD
QM02AC99
camphor, salicylic acid
7,5g/50g+ 3,75g/50g
ointment
aluminium tube 50g
Prescription
Registered
2020-06-02
1 LEAFLET FOR: CAMPHOR – SALICYLIC ACID OINTMENT CAMPHOR-SALICYLICUM OINTMENT For cattle, horses, donkeys, sheep, goats, dogs and cats 1. NAME AND ADDRESS OF THE AUTHORIZATION HOLDER AND OF THE PRODUCER (IF THEY DIFFERENT) VETPROM AD, 2400, Radomir, Bulgaria, 26, Otets Paisij Str. Tel.:+359 2 45 19 300 E-mail: office@vpharma.bg 2. NAME OF THE VETERINARY MEDICINAL PRODUCT CAMPHOR – SALICYLIC ACID OINTMENT CAMPHOR - SALICYLICUM OINTMENT 3. ACTIVE SUBSTANCE AND EXCIPIENTS 50 g of the ointment contain: ACTIVE SUBSTANCE: Camphor 7.5 g Salicylic Acid 3.75 g EXCIPIENTS: Colloidal anhydrous silica, sunflower oil, wool fat, white soft paraffin 4. THERAPEUTIC INDICATIONS Used in rheumatic and traumatic inflammations of the muscles and joints; tendinitis, tendovaginitis and bursitis; injuries class I and class II; periostitis, synovitis, neuritis, abscesses, phlegmons and other diseases of the musculoskeletal system. Mastitis (acute and chronic), mammary gland edema. 5. CONTRAINDICATIONS This drug product is contraindicated in animals with a history of sensitivity to any of its components. Not to be administered in the conjunctiva, because it causes local irritation! 6. ADVERSE REACTIONS 2 Skin irritations are possible. The frequency of the adverse reactions is defined using the following classification: - very common (more than 1 of 10 animals suffer from the ADR during one treatment course); - frequent (more than 1 but less than 10 animals out of 100 animals); - infrequent (more than 1 but less than 10 animals out of 1 000 animals) - rare (more than 1 but less than 10 animals out of 10 000 animals); - very rare (less than 1 animal out of 10 000 animals, including isolated reports). If a serious impact or other effect, due to the use of this VMP not listed in this leaflet is observed, please inform your veterinarian immediately. 7. ANIMAL SPECIES, FOR WHICH THIS VMP IS DESIGNED Cattle, horses, donkeys, sheep, goats, dogs and cats 8. RECOMMENDED DOSES FOR EACH OF THE ANIMAL SPECIES, ADMINISTRATION ROUTE For external use Leggi il documento completo
SUMMARY PRODUCT CHARACTERISTIC CAMPHOR-SALICYLICUM OINTMENT 1. NAME OF THE VMP AND CONCENTRATION / ACTIVITY. КАМФОР- САЛИЦИЛИКУМ маз CAMPHOR-SALICYLICUM ointment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Camphor 7.5 g/50 g Salicylic Acid 3.75 g/50 g EXCIPIENTS: For the full list of the excipients, see p. 6.1. 3. PHARMACEUTICAL FORM. Ointment for skin application. 4. CLINICAL DATA. 4.1. ANIMALS FOR WHICH THE VMP IS INTENDED. Cattle, horses, donkeys, pigs, sheep, goats, dogs and cats. 4.2. THERAPEUTIC INDICATIONS FOR INDIVIDUAL ANIMAL SPECIES Rheumatic and traumatic inflammation of the muscles and joints; tendinitis, tendovaginitis and bursitis; Type I and II strokes; periodites, synovitis, neuritis, abscesses, phlegmon and other diseases of the locomotor system. Mastitis (acute and chronic), breast oedema. 4.3. CONTRAINDICATIONS. Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not apply conjunctively due to local irritation! 4.4. SPECIAL PRECAUTIONS FOR THE ANIMALS FOR WHICH IT IS INTENDED. None. 4.5. SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Not applicable. Special precautions to be taken by the person administering the veterinary medicinal product to animals Not applicable. 4.6. ADVERSE REACTIONS (FREQUENCY AND IMPORTANCE) Photosensitivity reactions and skin rashes may occur. The frequency of adverse reactions is determined by the following classification: - very common (more than 1 in 10 animals exhibiting adverse reactions during the course of one treatment) - common (more than 1 but less than 10 animals per 100 animals) - uncommon (more than 1 but less than 10 animals per 1,000 animals) - rare (more than 1 but less than 10 animals per 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated messages). 4.7. USE DURING PREGNANCY, LACTATION OR LAYING. It can be used during pregnancy and lactation. 4.8. INTERACTION WITH OTHER VETERINARY MEDICINAL PRODUCTS AND OTHER FORMS OF Leggi il documento completo